Epidemiología de las enfermedades cardiovasculares: una revisión narrativa
DOI:
https://doi.org/10.47230/unesum-ciencias.v8.n1.2024.61-74Palabras clave:
ictus, cardiopatías, prevalencia, factores de riesgo, comorbilidadesResumen
Las enfermedades cardiovasculares (ECV), principalmente la cardiopatía isquémica y los accidentes cerebrovasculares, son la principal causa de mortalidad mundial y un importante contribuyente a la discapacidad. La carga de las ECV se ve influida por determinantes genéticos, metabólicos, comportamentales, ambientales y sociales. Sin embargo, la baja actividad física y la presión arterial desempeñan un papel central como factores de riesgo para las ECV. Los casos prevalentes de ECV son de 523 millones en el 2019 y el número de muertes por estas patologías aumentó constantemente hasta alcanzar 18,6 millones en el mismo periodo, por lo que, en la actualidad, la cardiopatía y los accidentes cerebrovasculares fueron la primera y la segunda causa de muerte en América, mientras que a nivel mundial, el accidente cerebrovascular siguió siendo la segunda causa de muerte. Es evidente que monitorear la carga de las enfermedades cardiovasculares es de vital importancia, este artículo revisa la epidemiología total de estas, incluidas las causas subyacentes de muerte cardiovascular y los factores de riesgo relacionados, utilizando estimaciones mundiales y fuentes de datos disponibles a nivel de población sobre incidencia, prevalencia, letalidad, mortalidad y riesgos para la salud en los países de América Latina y el mundo en los últimos cinco años, de allí que se plantea esta actualización narrativa de diseño documental, que pretende aportar al conocimiento de este importante problema de salud pública, contribuyendo a las acciones de prevención e intervenciones efectivas para frenar la carga de las enfermedades ECV, especialmente en las regiones con índices sociodemográficos más bajos.
Descargas
Citas
Ahmad, A., Lim, L. L., Morieri, M. L., Tam, C. H., Cheng, F., Chikowore, T., Dudenhöffer-Pfeifer, M., Fitipaldi, H., Huang, C., Kanbour, S., Sarkar, S., Koivula, R. W., Motala, A. A., Tye, S. C., Yu, G., Zhang, Y., Provenzano, M., Sherifali, D., de Souza, R. J., Tobias, D. K., … Mathioudakis, N. (2024). Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis. Communications medicine, 4(1), 11. https://doi.org/10.1038/s43856-023-00429-z
Baldeón ME, Felix C, Fornasini M, Zertuche F, Largo C, Paucar MJ, et al. (2021) Prevalence of metabolic syndrome and diabetes mellitus type-2 and their association with intake of dairy and legume in Andean communities of Ecuador. PLoS ONE 16(7): e0254812. https://doi.org/10.1371/journal.pone.0254812
Banach, M., Penson, P. E., Farnier, M., Fras, Z., Latkovskis, G., Laufs, U., Paneni, F., Parini, P., Pirro, M., Reiner, Ž., Vrablik, M., & Escobar, C. (2023). Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP). Progress in cardiovascular diseases, 79, 2–11. https://doi.org/10.1016/j.pcad.2023.03.001
Batista Mendoza, G., Giraldo Puentes, G. A., Rosero Palacios, E., Brett Cano, P. J., Ramírez Reyes, K. T., Zapata Valencia, C. M., Suarez Uribe, Y. L., Reyes, A. F., & Acuña Picón-Jaimes, Y. A. (2023). Investigación latinoamericana en falla cardiaca: análisis visual y bibliométrico de los últimos 20 años. Archivos peruanos de cardiología y cirugía cardiovascular, 4(4), 141–150. https://doi.org/10.47487/apcyccv.v4i4.328.
Camacho, X., Nedkoff, L., Wright, F. L., Nghiem, N., Buajitti, E., Goldacre, R., Rosella, L. C., Seminog, O., Tan, E. J., Hayes, A., Hayen, A., Wilson, N., Blakely, T., & Clarke, P. (2022). Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1•95 million events in 80•4 million people in four countries. The Lancet. Public health, 7(3), e229–e239. https://doi.org/10.1016/S2468-2667(22)00006-8
Camps-Vilaró, A., Subirana, I., Elosua, R., Palomo, I., Sanchis, J., Tizón-Marcos, H., Cainzos-Achirica, M., Sala, J., Masia, R., Ramos, R., Dégano, I. R., & Marrugat, J. (2023). Analysis of myocardial infarction incidence and case-fatality in the last three decades in the province of Girona. Revista Española de Cardiologia (English ed.), S1885-5857(23)00307-9. Advance online publication. https://doi.org/10.1016/j.rec.2023.10.005
Chia, S. P. S., Pang, J. K. S., & Soh, B. S. (2024). Current RNA strategies in treating cardiovascular diseases. Molecular therapy: the journal of the American Society of Gene Therapy, 32(3), 580–608. https://doi.org/10.1016/j.ymthe.2024.01.028
Chung, S. T., Krenek, A., & Magge, S. N. (2023). Childhood Obesity and Cardiovascular Disease Risk. Current atherosclerosis reports, 25(7), 405–415. https://doi.org/10.1007/s11883-023-01111-4
Delcuratolo, E., Palazzuoli, A., Coppi, F., Mattioli, A. V., Severino, P., Tramonte, F., & Fedele, F. (2023). Risk Factors and Cellular Differences in Heart Failure: The Key Role of Sex Hormones. Biomedicines, 11(11), 3052. https://doi.org/10.3390/biomedicines11113052
Di Cesare, M., Perel, P., Taylor, S., Kabudula, C., Bixby, H., Gaziano, T. A., McGhie, D. V., Mwangi, J., Pervan, B., Narula, J., Pineiro, D., & Pinto, F. J. (2024). The Heart of the World. Global heart, 19(1), 11. https://doi.org/10.5334/gh.1288
Duran, M., Gómez, J., & Villasmil, G. (2023). Racionamiento, inflación e inequidad sanitaria en Venezuela: caso de las enfermedades cardiovasculares. Revista Digital De Postgrado, 12(3), e379. https://doi.org/10.37910/RDP.2023.12.3.e379
Dutta, P., Saha, D., Earle, M., Prasad, C. P., Singh, M., Darswal, M., Aggarwal, V., Naik, N., Yadav, R., Shankar, A., & Chakraborty, A. (2024). Unveiling HPV's hidden link: Cardiovascular diseases and the viral intrigue. Indian heart journal, 76(1), 1–5. https://doi.org/10.1016/j.ihj.2024.02.001
El Husseini, N., Katzan, I. L., Rost, N. S., Blake, M. L., Byun, E., Pendlebury, S. T., & American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health (2023). Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement from the American Heart Association/American Stroke Association. Stroke, 54(6), e272–e291. https://doi.org/10.1161/STR.0000000000000430
Flores, A., Saelzer, L., Cartagena-Ramos, D. (2023). Determinantes Sociales de la Salud que influyen en la incidencia/prevalencia de las enfermedades cardiovasculares. Salud, Ciencia y Tecnología, 3:343. https://doi.org/10.56294/saludcyt2023343
Fu, X., Wang, J., Jiang, S., Wu, J., Mu, Z., Tang, Y., Wang, S., Fu, H., Ma, H., & Zhao, Y. (2023). Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis. BMC public health, 23(1), 644. https://doi.org/10.1186/s12889-023-15549-3
GBD 2019 Diseases and Injuries Collaborators (2020a). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England), 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
GBD 2019 Risk Factors Collaborators (2020b). Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England), 396(10258), 1223–1249. https://doi.org/10.1016/S0140-6736(20)30752-2
GBD 2019 Stroke Collaborators (2021). Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. Neurology, 20(10), 795–820. https://doi.org/10.1016/S1474-4422(21)00252-0
Ismail, T. F., Frey, S., Kaufmann, B. A., Winkel, D. J., Boll, D. T., Zellweger, M. J., & Haaf, P. (2023). Hypertensive Heart Disease-The Imaging Perspective. Journal of clinical medicine, 12(9), 3122. https://doi.org/10.3390/jcm12093122
Jia, G., Bai, H., Mather, B., Hill, M. A., Jia, G., & Sowers, J. R. (2024). Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights. International journal of molecular sciences, 25(2), 804. https://doi.org/10.3390/ijms25020804
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; and Council on Hypertension (2022). Comprehensive Management of Cardiovascular Risk Factors for Adults with Type 2 Diabetes: A Scientific Statement from the American Heart Association. Circulation, 145(9), e722–e759. https://doi.org/10.1161/CIR.0000000000001040
Julián, M. T., Pérez-Montes de Oca, A., Julve, J., & Alonso, N. (2024). The double burden: type 1 diabetes and heart failure-a comprehensive review. Cardiovascular diabetology, 23(1), 65. https://doi.org/10.1186/s12933-024-02136-y
Khanna, N. N., Singh, M., Maindarkar, M., Kumar, A., Johri, A. M., Mentella, L., et al. (2023). Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review. Journal of Korean medical science, 38(46), e395. https://doi.org/10.3346/jkms.2023.38.e395
Krämer, C., Meisinger, C., Kirchberger, I., Heier, M., Kuch, B., Thilo, C., Linseisen, J., & Amann, U. (2021). Epidemiological trends in mortality, event rates and case fatality of acute myocardial infarction from 2004 to 2015: results from the KORA MI registry. Annals of medicine, 53(1), 2142–2152. https://doi.org/10.1080/07853890.2021.2002926
Liang, R., Feng, X., Shi, D., Yang, M., Yu, L., Liu, W., Zhou, M., Wang, X., Qiu, W., Fan, L., Wang, B., & Chen, W. (2022). The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019. Diabetes/metabolism research and reviews, 38(8), e3572. https://doi.org/10.1002/dmrr.3572
Linz, D., Gawalko, M., Betz, K., Hendriks, J. M., Lip, G. Y. H., Vinter, N., Guo, Y., & Johnsen, S. (2024). Atrial fibrillation: epidemiology, screening and digital health. The Lancet regional health. Europe, 37, 100786. https://doi.org/10.1016/j.lanepe.2023.100786
Liu, J., Ma, J., Orekoya, O., Vangeepuram, N., & Liu, J. (2022). Trends in Metabolic Syndrome Among US Youth, From 1999 to 2018. JAMA pediatrics, 176(10), 1043–1045. https://doi.org/10.1001/jamapediatrics.2022.1850
López-Jaramillo, P., López-López, J.P. (2023). Factores de riesgo y muerte cardiovascular en América del Sur. Clínica e Investigación en Arteriosclerosis, 35 (4), 195-200. https://doi.org/10.1016/j.arteri.2022.12.001
López- Panata, J. A., Quishpe Jara, G. de las M., & Villacís-Valencia, S. E. (2022). Factores de riesgo de enfermedades cardiovasculares en adultos jóvenes. Investigación Y Desarrollo, 16(1). https://doi.org/10.31243/id.v16.2022.1834
Luo, Y., Liu, J., Zeng, J., & Pan, H. (2024). Global burden of cardiovascular diseases attributed to low physical activity: An analysis of 204 countries and territories between 1990 and 2019. American journal of preventive cardiology, 17, 100633. https://doi.org/10.1016/j.ajpc.2024.100633
Martin C. M. (2024). Cardiomyopathies in Women. Methodist DeBakey cardiovascular journal, 20(2), 59–69. https://doi.org/10.14797/mdcvj.1368
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2024). 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data from the American Heart Association. Circulation, 149(8), e347–e913. https://doi.org/10.1161/CIR.0000000000001209
Martínez, R., Soliz, P., Campbell, N. R. C., Lackland, D. T., Whelton, P. K., & Ordúñez, P. (2023). Association between population hypertension control and ischemic heart disease and stroke mortality in 36 countries of the Americas, 1990-2019: an ecological study. Pan American journal of public health, 47, e124. https://doi.org/10.26633/RPSP.2023.124
Morales-Villegas, E.C., Yarleque, C., Almeida, M. L. (2023). Management of hypertension and dyslipidemia in Mexico: evidence, gaps, and approach. Archivos de cardiología de México, 93(1), 77-87. https://doi.org/10.24875/acm.21000330
Moreno, S. V., Uddin, R., McNaughton, S. A., Livingstone, K. M., George, E. S., Siopis, G., Maddison, R., Huxley, R. R., & Islam, S. M. S. (2024). The burden of cardiovascular disease attributable to dietary risk factors in Australia between 1990 and 2019. PloS one, 19(1), e0295231. https://doi.org/10.1371/journal.pone.0295231
Nawsherwan, Mubarik, S., Bin, W., Le, Z., Sang, M., Lin, Y., Zheng, J., & Wang, Y. (2023). Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transitions across BRICS-Plus Countries. Nutrients, 15(17), 3757. https://doi.org/10.3390/nu15173757
NCD Risk Factor Collaboration (NCD-RisC) (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet (London, England), 398(10304), 957–980. https://doi.org/10.1016/S0140-6736(21)01330-1
Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., American Heart Association (2023). A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement from the American Heart Association. Circulation, 148(20), 1636–1664. https://doi.org/10.1161/CIR.0000000000001186
Nemtsova, V., Vischer, A. S., & Burkard, T. (2023). Hypertensive Heart Disease: A Narrative Review Series-Part 1: Pathophysiology and Microstructural Changes. Journal of clinical medicine, 12(7), 2606. https://doi.org/10.3390/jcm12072606
O'Hearn, M., Lauren, B. N., Wong, J. B., Kim, D. D., & Mozaffarian, D. (2022). Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. Journal of the American College of Cardiology, 80(2), 138–151. https://doi.org/10.1016/j.jacc.2022.04.046
Ordunez, P., Campbell, N. R. C., DiPette, D. J., Jaffe, M. G., Rosende, A., Martínez, R., Gamarra, A., Lombardi, C., Parra, N., Rodríguez, L., Rodríguez, Y., & Brettler, J. (2024). HEARTS in the Americas: targeting health system change to improve population hypertension control. Pan American journal of public health, 48, e17. https://doi.org/10.26633/RPSP.2024.17
Qu, C., Liao, S., Zhang, J., Cao, H., Zhang, H., Zhang, N., Yan, L., Cui, G., Luo, P., Zhang, Q., & Cheng, Q. (2024). Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. European heart journal. Quality of care & clinical outcomes, 10(2), 143–153. https://doi.org/10.1093/ehjqcco/qcad033
Reiffel J. A. (2024). Selected Advances in the Anti-arrhythmic Management of Atrial Fibrillation: 2023. The Journal of innovations in cardiac rhythm management, 15(1), 5728–5734. https://doi.org/10.19102/icrm.2024.15014
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group (2020). Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76(25), 2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Rus, M., Crisan, S., Andronie-Cioara, F. L., Indries, M., Marian, P., Pobirci, O. L., & Ardelean, A. I. (2023). Prevalence and Risk Factors of Metabolic Syndrome: A Prospective Study on Cardiovascular Health. Medicina (Kaunas, Lithuania), 59(10), 1711. https://doi.org/10.3390/medicina59101711
Safiri, S., Karamzad, N., Singh, K., Carson-Chahhoud, K., Adams, C., Nejadghaderi, S. A., Almasi-Hashiani, A., Sullman, M. J. M., Mansournia, M. A., Bragazzi, N. L., Kaufman, J. S., Collins, G. S., & Kolahi, A. A. (2022). Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019. European journal of preventive cardiology, 29(2), 420–431. https://doi.org/10.1093/eurjpc/zwab213
Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., & Coats, A. J. S. (2023). Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovascular research, 118(17), 3272–3287. https://doi.org/10.1093/cvr/cvac013
Shen, N., Liu, J., Wang, Y., Qiu, Y., Li, D., Wang, Q., Chai, L., Chen, Y., Hu, H., & Li, M. (2024). The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019. Heliyon, 10(5), e27065. https://doi.org/10.1016/j.heliyon.2024.e27065.
Sohani, Z. N., Behlouli, H., de Moura, C. S., Abrahamowicz, M., & Pilote, L. (2023). Sex Differences in the Effectiveness of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril-Valsartan for the Treatment of Heart Failure. Journal of the American Heart Association, 12(14), e028865. https://doi.org/10.1161/JAHA.122.028865
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., Pavkov, M. E., Ramachandaran, A., Wild, S. H., James, S., Herman, W. H., Zhang, P., Bommer, C., Kuo, S., Boyko, E. J., & Magliano, D. J. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes research and clinical practice, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119
Taghian, G., Fisher, S., Chiles, T. C., Binagwaho, A., & Landrigan, P. J. (2024). The Burden of Cardiovascular Disease from Air Pollution in Rwanda. Annals of global health, 90(1), 2. https://doi.org/10.5334/aogh.4322
Troncoso-Pantoja C, Martínez-Sanguinetti MA, Ulloa N, Celis-Morales C. Cardiovascular disease cases can be attributed to risk factors that could be modified with lifestyle changes. Rev Med Chil. 2020;148(1):126–8. https://doi/10.4067/S0034-98872020000100126
United Nations Department of Economic and Social Affairs, Population Division (2020). World Population Ageing 2020 Highlights: Living arrangements of older persons (ST/ESA/SER.A/451). This report is available in electronic format on the Division’s website at: www.un.org/development/desa/pd/.
Ventoulis, I., Kamperidis, V., Abraham, M. R., Abraham, T., Boultadakis, A., Tsioukras, E., Katsiana, A., Georgiou, K., Parissis, J., & Polyzogopoulou, E. (2024). Differences in Health-Related Quality of Life among Patients with Heart Failure. Medicina (Kaunas, Lithuania), 60(1), 109. https://doi.org/10.3390/medicina60010109.
Vinci, P., Di Girolamo, F. G., Panizon, E., Tosoni, L. M., Cerrato, C., Pellicori, F., Altamura, N., Pirulli, A., Zaccari, M., Biasinutto, C., Roni, C., Fiotti, N., Schincariol, P., Mangogna, A., & Biolo, G. (2023). Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives. International journal of environmental research and public health, 20(18), 6721. https://doi.org/10.3390/ijerph20186721
